GO:0035305 negative regulation of dephosphorylation: Signaling Brake, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035305 (negative regulation of dephosphorylation) describes any process that stops, prevents, or reduces the removal of phosphate groups from a molecule, thereby preserving phosphorylation states.
• It is a biological_process ontology term that acts as a signaling brake, counteracting phosphatases and maintaining kinase-driven phosphorylation.
• Key molecular players include PTEN, which negatively regulates PKB/Akt-dependent cell survival by opposing dephosphorylation, and VRK3, which activates VHR phosphatase to inhibit ERK activity.
• Dysregulation of this process is linked to cancer, neurodegeneration, and immune disorders through altered phospho-signaling.
• Experimental models such as knockout, point-mutation, and knock-in cell lines are essential to dissect causal roles of genes in this process.
• CRISPR-based screening and bioinformatics enable systematic discovery of regulators of dephosphorylation.
Description
GO:0035305, negative regulation of dephosphorylation, is a biological process that stops, prevents, or reduces the frequency, rate, or extent of removal of phosphate groups from a molecule. This term captures a critical layer of cellular control where phosphatases are inhibited or their access to substrates is blocked, thereby preserving phosphorylation states that drive signaling, cell cycle progression, and survival. Researchers study this process because it directly modulates the balance between kinases and phosphatases, influencing outcomes such as cell cycle arrest, immune responses, and neuronal plasticity. For example, pRB dephosphorylation is required for cell cycle regulation, and its negative regulation ensures timely progression. Similarly, negative regulation of antigen receptor signaling in lymphocytes depends on preventing dephosphorylation of key signaling intermediates. In neurons, regulation of AMPA receptor dephosphorylation by glutamate receptor agonists highlights how this process shapes synaptic strength. Thus, understanding GO:0035305 is essential for decoding how cells maintain signaling fidelity and respond to external cues.
negative regulation of dephosphorylation At A Glance
| GO ID | GO:0035305 |
|---|---|
| GO term | negative regulation of dephosphorylation |
| Ontology | biological_process |
| Synonym | down regulation of dephosphorylation; down-regulation of dephosphorylation; downregulation of dephosphorylation; inhibition of dephosphorylation |
| Definition | Any process that stops, prevents, or reduces the frequency, rate or extent of removal of phosphate groups from a molecule. |
| Major function | Preserves phosphorylation states by inhibiting phosphatases or blocking substrate access, thereby modulating signaling pathways. |
| Related processes | Cell cycle regulation, immune signaling, neuronal plasticity, and cell survival. |
| Key regulators | PTEN, VRK3, TULA-family proteins, and cell adhesion-dependent STAT1 dephosphorylation. |
What Is GO:0035305?
According to the Gene Ontology, GO:0035305 (negative regulation of dephosphorylation) is defined as any process that stops, prevents, or reduces the frequency, rate or extent of removal of phosphate groups from a molecule. In other words, it is a regulatory mechanism that inhibits phosphatases or blocks their access to substrates, leading to a net increase in phosphorylation. This process is distinct from positive regulation of phosphorylation; it acts by suppressing the removal of phosphate groups rather than by adding them. It is a biological_process term with synonyms including down regulation of dephosphorylation, down-regulation of dephosphorylation, downregulation of dephosphorylation, and inhibition of dephosphorylation.
Why Is negative regulation of dephosphorylation Important in Cell Biology?
Negative regulation of dephosphorylation is important because it provides a critical brake on phosphatase activity, ensuring that phosphorylation-dependent signals are not prematurely terminated. This process influences fundamental decisions such as whether a cell divides, survives, or dies. In lymphocytes, it helps set thresholds for antigen receptor signaling, preventing inappropriate activation. In the brain, it modulates AMPA receptor function and synaptic plasticity. Dysregulation of this process can lead to cancer, autoimmunity, and neurodegeneration, making it a prime target for therapeutic intervention and a focus for CRISPR-based functional studies.
• Maintains phosphorylation balance by counteracting phosphatases, which is essential for signal transduction fidelity.
• Controls cell cycle progression through regulation of pRB dephosphorylation.
• Modulates immune responses by influencing antigen receptor signaling in lymphocytes.
• Regulates interferon-γ/STAT1 signaling via cell adhesion and density-dependent STAT1 dephosphorylation.
• Shapes synaptic plasticity by regulating AMPA receptor dephosphorylation in neurons.
• Links to mitophagy and neurodegeneration through PPP2/PP2A-mediated dephosphorylation of LC3B.
• Involves TULA-family regulators in platelet activation, affecting thrombosis.
• Negatively regulates ERK activity via VRK3-mediated activation of VHR phosphatase.
• Tumor suppressor PTEN negatively regulates PKB/Akt-dependent cell survival, highlighting its role in cancer.
• Provides a mechanism for cell density and adhesion to tune signaling outcomes.
What Happens During negative regulation of dephosphorylation?
Initiation: Sensing the Need to Preserve Phosphorylation
In simple terms: The cell detects a signal that requires keeping phosphate groups on target proteins.
Negative regulation of dephosphorylation is initiated when cellular cues, such as cell adhesion or receptor engagement, trigger pathways that inhibit phosphatases or block their access to substrates. For instance, cell adhesion and cell density can lead to STAT1 dephosphorylation being negatively regulated, preserving STAT1 phosphorylation. Similarly, antigen receptor signaling in lymphocytes is negatively regulated to prevent excessive dephosphorylation of signaling molecules.
Execution: Inhibition of Phosphatase Activity or Substrate Access
In simple terms: The cell uses specific proteins to stop phosphatases from removing phosphate groups.
Execution involves direct inhibition of phosphatases or sequestration of substrates. VRK3 activates VHR phosphatase, which then negatively regulates ERK activity by dephosphorylating it, but this is an example of negative regulation of ERK, not dephosphorylation; however, the term encompasses processes that reduce dephosphorylation of other targets. PTEN negatively regulates PKB/Akt-dependent cell survival by opposing dephosphorylation of Akt. In platelets, TULA-family proteins regulate activation by modulating dephosphorylation events.
Maintenance: Sustaining the Phosphorylated State
In simple terms: Once phosphate groups are preserved, the cell maintains them to keep signaling active.
Maintenance of phosphorylation is achieved through sustained inhibition of phosphatases. For example, negative regulation of pRB dephosphorylation ensures that pRB remains phosphorylated to allow cell cycle progression. In neurons, glutamate receptor agonists regulate AMPA receptor dephosphorylation, and negative regulation of this process helps sustain receptor phosphorylation for synaptic plasticity.
Termination: Reversal of the Brake
In simple terms: When the signal ends, the brake is released, and phosphatases can act again.
Termination occurs when the inhibitory signals wane, allowing phosphatases to remove phosphate groups. This reversal is critical for resetting signaling pathways. For instance, after cell density changes, STAT1 dephosphorylation is no longer negatively regulated, leading to signal termination. Similarly, in mitophagy, PPP2/PP2A-mediated dephosphorylation of LC3B is linked to SCA12 pathogenesis, and its negative regulation would prevent this.
Key Genes Involved in GO:0035305 negative regulation of dephosphorylation
The following genes and proteins are key players in negative regulation of dephosphorylation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTEN | Negatively regulates PKB/Akt-dependent cell survival by opposing dephosphorylation | Tumor suppressor, cancer research |
| VRK3 | Activates VHR phosphatase to negatively regulate ERK activity | Signaling regulation, cancer |
| TULA-family | Regulators of platelet activation via modulation of dephosphorylation | Thrombosis, platelet biology |
| STAT1 | Negatively regulated by cell adhesion and density-dependent dephosphorylation | Immune signaling, interferon responses |
| pRB | Dephosphorylation is negatively regulated for cell cycle progression | Cell cycle, cancer |
| AMPA receptor | Dephosphorylation regulated by glutamate receptor agonists | Synaptic plasticity, neuroscience |
| LC3B | PPP2/PP2A-mediated dephosphorylation links to mitophagy and SCA12 | Neurodegeneration, autophagy |
| PKB/Akt | Negatively regulated by PTEN to control cell survival | Cancer, metabolism |
| ERK | Negatively regulated by VRK3-VHR axis | MAPK signaling, cancer |
| VHR | Phosphatase activated by VRK3 to dephosphorylate ERK | Signaling, cancer |
| PPP2/PP2A | Phosphatase that dephosphorylates LC3B | Autophagy, neurodegeneration |
| PINK1 | Kinase in mitophagy pathway linked to LC3B dephosphorylation | Mitophagy, Parkinson's disease |
| PRKN/Parkin | E3 ubiquitin ligase in mitophagy, linked to LC3B dephosphorylation | Mitophagy, Parkinson's disease |
| Antigen receptor | Signaling negatively regulated in lymphocytes | Immunology, autoimmunity |
| Glutamate receptor | Regulates AMPA receptor dephosphorylation | Neuroscience, synaptic plasticity |
| Cell adhesion molecules | Mediate cell density-dependent STAT1 dephosphorylation | Cell biology, immune regulation |
| TULA-2 | Member of TULA-family regulating platelet activation | Thrombosis |
How Is negative regulation of dephosphorylation Regulated?
Negative regulation of dephosphorylation is itself regulated by upstream signals such as cell adhesion, cell density, and receptor activation. For example, cell adhesion and cell density negatively regulate STAT1 dephosphorylation, meaning that when cells are adherent or dense, dephosphorylation is inhibited. In lymphocytes, antigen receptor signaling is negatively regulated, which involves preventing dephosphorylation of key signaling molecules. Additionally, VRK3-mediated activation of VHR phosphatase negatively regulates ERK activity, illustrating a kinase-phosphatase axis. PTEN negatively regulates PKB/Akt-dependent cell survival by opposing dephosphorylation, linking this process to PI3K signaling. These regulatory inputs ensure that dephosphorylation is tightly controlled in space and time.
negative regulation of dephosphorylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Cancer (e.g., glioblastoma, prostate cancer) | PTEN knockout cell lines, point mutations |
| PPP2/PP2A | SCA12 neurodegeneration | Knock-in of mutant PPP2/PP2A, LC3B dephosphorylation assays |
| VRK3 | Cancer, MAPK signaling dysregulation | VRK3 knockout and overexpression models |
| STAT1 | Immune disorders, interferonopathies | STAT1 point mutations, cell adhesion models |
| TULA-family | Thrombosis, platelet disorders | TULA-2 knockout platelets, knock-in models |
Cancer
Dysregulation of negative regulation of dephosphorylation can lead to uncontrolled cell survival and proliferation. PTEN, a tumor suppressor, negatively regulates PKB/Akt-dependent cell survival by opposing dephosphorylation; loss of PTEN results in increased Akt phosphorylation and cancer progression. Similarly, negative regulation of pRB dephosphorylation is critical for cell cycle control, and its disruption can contribute to tumorigenesis. VRK3-mediated negative regulation of ERK activity also plays a role in cancer signaling.
Neurodegeneration
In neurodegeneration, PPP2/PP2A-mediated dephosphorylation of LC3B links PINK1-PRKN/Parkin-mediated mitophagy to SCA12 pathogenesis. Negative regulation of this dephosphorylation event may protect against mitochondrial dysfunction and neuronal death. Additionally, regulation of AMPA receptor dephosphorylation by glutamate receptor agonists is important for synaptic plasticity, and its dysregulation is implicated in neurological disorders.
Immune Disorders
Negative regulation of antigen receptor signaling in lymphocytes is essential for preventing autoimmunity. Cell adhesion and cell density-dependent STAT1 dephosphorylation negatively regulates interferon-γ/STAT1 signaling, and defects in this process can lead to immune dysregulation. TULA-family regulators of platelet activation also highlight the importance of dephosphorylation control in thrombosis and hemostasis.
From negative regulation of dephosphorylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PTEN affect negative regulation of dephosphorylation? | PTEN knockout cell line |
| How do point mutations in STAT1 alter dephosphorylation regulation? | STAT1 point-mutation knock-in |
| Can overexpression of VRK3 enhance negative regulation of ERK dephosphorylation? | VRK3 overexpression |
| What is the role of PPP2/PP2A in LC3B dephosphorylation? | PPP2/PP2A knockout or knock-in |
| How does TULA-2 regulate platelet dephosphorylation? | TULA-2 knockout mouse or cell line |
| Does cell density affect STAT1 dephosphorylation? | Cell adhesion and density-controlled STAT1 reporter |
How to Study the negative regulation of dephosphorylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Identify substrates of negative regulation |
| Western blotting | Phosphorylation status of specific proteins | Validate signaling changes |
| CRISPR screens | Genes affecting dephosphorylation | Discover novel regulators |
| FRET biosensors | Real-time phosphorylation dynamics | Live-cell imaging |
| Co-immunoprecipitation | Protein-protein interactions | Identify phosphatase-regulator complexes |
| In vitro phosphatase assays | Phosphatase activity | Measure direct inhibition |
| RNA-seq | Transcriptional changes | Assess downstream effects |
| Immunofluorescence | Subcellular localization of phosphoproteins | Tissue or cell imaging |
Phosphoproteomics
Phosphoproteomics allows global profiling of phosphorylation changes when negative regulation of dephosphorylation is perturbed. By comparing wild-type and knockout cells, researchers can identify specific phosphosites that are preserved due to inhibited dephosphorylation.
Western Blotting with Phospho-specific Antibodies
Western blotting using phospho-specific antibodies is a classic method to monitor the phosphorylation status of key proteins such as Akt, ERK, STAT1, and pRB. It can reveal whether negative regulation of dephosphorylation is active.
CRISPR Screens
Genome-wide CRISPR screens can identify genes whose knockout alters dephosphorylation of a reporter. This approach uncovers novel regulators of GO:0035305.
Live-cell Imaging with FRET Biosensors
FRET-based biosensors can dynamically monitor phosphorylation and dephosphorylation events in live cells, providing spatial and temporal resolution of negative regulation.
How CRISPR Can Be Used to Study GO:0035305 negative regulation of dephosphorylation
Knockout
CRISPR knockout of genes such as PTEN or VRK3 can abolish negative regulation of dephosphorylation, leading to increased dephosphorylation of targets like Akt or ERK. These models are essential to establish causality.
Point Mutation
Point mutations can mimic disease-associated variants in genes like STAT1 or PPP2/PP2A, altering their ability to negatively regulate dephosphorylation. Such models help dissect specific residues required for function.
Knock-in
Knock-in of tagged or mutant versions of genes (e.g., TULA-2, LC3B) allows tracking of protein localization and function in the context of negative regulation of dephosphorylation.
Overexpression
Overexpression of negative regulators such as VRK3 or PTEN can enhance the brake on dephosphorylation, providing gain-of-function models to study signaling outcomes.
How EDITGENE Supports negative regulation of dephosphorylation Research
Researchers studying negative regulation of dephosphorylation-related genes often need to determine whether a candidate gene is causally involved in preserving phosphorylation states, or whether its effect is secondary. This requires precise genetic models that can isolate the contribution of specific genes to the process.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of dephosphorylation research.
Frequently Asked Questions About negative regulation of dephosphorylation
What is negative regulation of dephosphorylation?
It is a biological process (GO:0035305) that stops, prevents, or reduces the removal of phosphate groups from a molecule, thereby preserving phosphorylation.
What genes are involved in negative regulation of dephosphorylation?
Key genes include PTEN, VRK3, TULA-family, STAT1, pRB, AMPA receptor, LC3B, and PPP2/PP2A.
How does negative regulation of dephosphorylation affect cancer?
It can prevent dephosphorylation of oncogenic proteins like Akt, and its dysregulation contributes to cancer progression.
What diseases are linked to negative regulation of dephosphorylation?
Cancer, neurodegeneration (e.g., SCA12), immune disorders, and thrombosis.
What is the role of PTEN in negative regulation of dephosphorylation?
PTEN negatively regulates PKB/Akt-dependent cell survival by opposing dephosphorylation of Akt.
How can I study negative regulation of dephosphorylation in the lab?
Use phosphoproteomics, Western blotting, CRISPR screens, and FRET biosensors.
What are the research methods for GO:0035305?
Common methods include phosphoproteomics, Western blotting, CRISPR knockout/knock-in, and live-cell imaging.
Which CRISPR models are suitable for studying negative regulation of dephosphorylation?
Knockout, point mutation, knock-in, and overexpression models of genes like PTEN, VRK3, and STAT1.
What is the difference between negative regulation of dephosphorylation and positive regulation of phosphorylation?
Negative regulation of dephosphorylation inhibits phosphate removal, while positive regulation of phosphorylation promotes phosphate addition; both increase net phosphorylation but via distinct mechanisms.
Why is negative regulation of dephosphorylation important for cell signaling?
It maintains phosphorylation states that are critical for signal transduction, cell cycle control, and immune responses.
Conclusion
GO:0035305, negative regulation of dephosphorylation, is a fundamental biological process that preserves phosphorylation states by inhibiting phosphatases or blocking their access to substrates. It plays critical roles in cell cycle regulation, immune signaling, neuronal plasticity, and cell survival, with key regulators such as PTEN, VRK3, and PPP2/PP2A. Dysregulation of this process is implicated in cancer, neurodegeneration, and immune disorders, making it a compelling target for research. Advances in CRISPR-based models and phosphoproteomics will continue to illuminate its mechanisms and therapeutic potential.
References
- 1. Tamrakar S et al.. 2000. Role of pRB dephosphorylation in cell cycle regulation.. Front Biosci 5:D121-37 PMID: 10702384
- 2. Plas DR et al.. 1998. Negative regulation of antigen receptor signaling in lymphocytes.. J Mol Med (Berl) 76(8):589-95 PMID: 9694436
- 3. Chen Z et al.. 2011. Negative regulation of interferon-γ/STAT1 signaling through cell adhesion and cell density-dependent STAT1 dephosphorylation.. Cell Signal 23(8):1404-12 PMID: 21511030
- 4. Snyder GL et al.. 2003. Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists.. Neuropharmacology 45(6):703-13 PMID: 14529709
- 5. Li N et al.. 2025. PPP2/PP2A-mediated dephosphorylation of LC3B links PINK1-PRKN/Parkin-mediated mitophagy to SCA12 pathogenesis.. Autophagy 21(12):3182-3194 PMID: 41059761
- 6. Kunapuli SP et al.. 2022. TULA-Family Regulators of Platelet Activation.. Int J Mol Sci 23(23) PMID: 36499237
- 7. Kang TH et al.. 2006. Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase.. Nat Cell Biol 8(8):863-9 PMID: 16845380
- 8. Stambolic V et al.. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.. Cell 95(1):29-39 PMID: 9778245
